ConductScience.org, home

Paper41007730

Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems.

Schreiner TG and 3 others. Biomedicines, 2025. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems. Papers, record 41007730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007730

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intrathecal Therapies for Neurodegenerative Diseases: A Review of Current Approaches and the Urgent Need for Advanced Delivery Systems.
PubMed
Journal
Biomedicines
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
7.65, provisional
iCite
Revised in PubMed
2025-09-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schreiner TGThomas Gabrielhttps://orcid.org/0000-0002-4495-4004
2Menéndez-González MManuelhttps://orcid.org/0000-0002-5218-0774
3Schreiner ODOliver Daniel
4Ciobanu RCRomeo Cristian

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References142

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136068427Approaches to Gene Modulation Therapy for ALS.Neurotherapeutics2022https://conductscience.org/library/papers/36068427PubMed
228780180Neuropathology of Parkinson disease.Parkinsonism Relat Disord2018https://conductscience.org/library/papers/28780180PubMed
335378156Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer's disease pathology in transgenic mouse model.Int J Biol Macromol2022https://conductscience.org/library/papers/35378156PubMed
437250416Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy.Front Neurosci2023https://conductscience.org/library/papers/37250416PubMed
535563214Advanced Gene-Targeting Therapies for Motor Neuron Diseases and Muscular Dystrophies.Int J Mol Sci2022https://conductscience.org/library/papers/35563214PubMed
627063658Cerebrospinal Fluid Dynamics and the Pathophysiology of Hydrocephalus: New Concepts.Semin Ultrasound CT MR2016https://conductscience.org/library/papers/27063658PubMed
739684197Advances and Challenges in Gene Therapy for Neurodegenerative Diseases: A Systematic Review.Int J Mol Sci2024https://conductscience.org/library/papers/39684197PubMed
835493843AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System.Front Neurol2022https://conductscience.org/library/papers/35493843PubMed
921343917Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.Mol Ther2011https://conductscience.org/library/papers/21343917PubMed
1027433993Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management.Neuromodulation2016https://conductscience.org/library/papers/27433993PubMed
1129443664Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.N Engl J Med2018https://conductscience.org/library/papers/29443664PubMed
1231243392AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy.Gene Ther2019https://conductscience.org/library/papers/31243392PubMed
1335221289Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.Drug Metab Dispos2022https://conductscience.org/library/papers/35221289PubMed
1432879313Circadian control of brain glymphatic and lymphatic fluid flow.Nat Commun2020https://conductscience.org/library/papers/32879313PubMed
1536674643Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives.Int J Mol Sci2023https://conductscience.org/library/papers/36674643PubMed
1638055260Tominersen in Adults with Manifest Huntington's Disease.N Engl J Med2023https://conductscience.org/library/papers/38055260PubMed
1739736972Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges.Front Med (Lausanne)2024https://conductscience.org/library/papers/39736972PubMed
1838527856APP antisense oligonucleotides reduce amyloid-β aggregation and rescue endolysosomal dysfunction in Alzheimer's disease.Brain2024https://conductscience.org/library/papers/38527856PubMed
1937302978GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.J Mov Disord2023https://conductscience.org/library/papers/37302978PubMed
2038294637Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.J Neurooncol2024https://conductscience.org/library/papers/38294637PubMed

See all 142 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42883972Advanced Drug Delivery in Pediatric Neurology: Developmental Barriers, Nanocarrier Strategies, and Translational Challenges.Int J Mol Sci2026https://conductscience.org/library/papers/42883972PubMed
42793044Decoding MAPT Exon 10 Mis-Splicing in FTDP-17: From Pathogenic Mechanisms and Experimental Models to Molecular Therapies.Genes (Basel)2026https://conductscience.org/library/papers/42793044PubMed
42756044Therapeutic strategies in prion disease: current evidence, translational challenges, and emerging directions.Front Neurosci2026https://conductscience.org/library/papers/42756044PubMed
42738833Application of Mesenchymal Stromal Cells and Their Exosomes in Neurodegenerative Diseases and Lysosomal Storage Diseases.Cells2026https://conductscience.org/library/papers/42738833PubMed
42667630Advanced Materials for Biologics Delivery to Brain Tumors.Adv Mater2026https://conductscience.org/library/papers/42667630PubMed
42633286SafeSense: An open-access safety atlas for antisense oligonucleotides adverse events in human.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42633286PubMed
42576199ADAR-mediated RNA editing in CNS disorders: from pathogenic mechanisms to therapeutic opportunities.Cell Mol Biol Lett2026https://conductscience.org/library/papers/42576199PubMed
42282541Lumbar intrathecal catheterization in rats targeting the cerebral cortex: a drug delivery method and validation.bioRxiv2026https://conductscience.org/library/papers/42282541PubMed
42279220Advanced Drug Delivery Strategies in Geriatric Patients with Polypharmacy: Integrating Pharmacokinetics, Personalized Medicine, and Emerging Technologies.J Clin Med2026https://conductscience.org/library/papers/42279220PubMed
42234836Peptide-Based Delivery Systems: Selected Insights into Cell-Penetrating Peptides.ACS Chem Neurosci2026https://conductscience.org/library/papers/42234836PubMed
42205472Variability in the circulation of cerebrospinal fluid: causes and clinical implications for intraventricular drug delivery.Front Drug Deliv2026https://conductscience.org/library/papers/42205472PubMed
42164918Toward nanomedicine-enabled RNA therapeutics for Alzheimer's disease.Mol Neurodegener Adv2026https://conductscience.org/library/papers/42164918PubMed
42147722Ultrasonic modulation of brain glymphatic transport: from observations to theranostic applications.Cancer Drug Resist2026https://conductscience.org/library/papers/42147722PubMed
42076121Locoregional Delivery of miRNAs for Glioblastoma Treatment: A Systematic Review of Advances in Delivery Systems.Pharmaceutics2026https://conductscience.org/library/papers/42076121PubMed
41828589From Polyphenols to Prodrugs: Bridging the Blood-Brain Barrier with Nanomedicine and Neurotherapeutics.Int J Mol Sci2026https://conductscience.org/library/papers/41828589PubMed
41595696Screen, Sample, Stratify: Biomarkers and Machine Learning Compress Dementia Pathways.Biomedicines2026https://conductscience.org/library/papers/41595696PubMed
41462898Unlocking the Sugar Code: Implications and Consequences of Glycosylation in Alzheimer's Disease and Other Tauopathies.Biomedicines2025https://conductscience.org/library/papers/41462898PubMed
41441314Parental Knowledge and Acceptance of Pediatric Lumbar Puncture in Northern Saudi Arabia: Implications for Clinical Practice and Education: A Cross-Sectional Study.Pediatr Rep2025https://conductscience.org/library/papers/41441314PubMed
41369342Orthobiologics and Peptide Therapy for Central Nervous System Repair in Neurodegenerative Conditions.Cells2025https://conductscience.org/library/papers/41369342PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007730

GET https://conductscience.org/api/papers/v1/41007730/references?page=2